Literature DB >> 22178181

Purification and characterization of riproximin from Ximenia americana fruit kernels.

Helene Bayer1, Noreen Ey, Andreas Wattenberg, Cristina Voss, Martin R Berger.   

Abstract

Highly pure riproximin was isolated from the fruit kernels of Ximenia americana, a defined, seasonally available and potentially unlimited herbal source. The newly established purification procedure included an initial aqueous extraction, removal of lipids with chloroform and subsequent chromatographic purification steps on a strong anion exchange resin and lactosyl-Sepharose. Consistent purity and stable biological properties were shown over several purification batches. The purified, kernel-derived riproximin was characterized in comparison to the African plant material riproximin and revealed highly similar biochemical and biological properties but differences in the electrophoresis pattern and mass spectrometry peptide profile. Our results suggest that although the purified fruit kernel riproximin consists of a mixture of closely related isoforms, it provides a reliable basis for further research and development of this type II ribosome inactivating protein (RIP). Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22178181     DOI: 10.1016/j.pep.2011.11.018

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  8 in total

1.  Evaluation of riproximin binding properties reveals a novel mechanism for cellular targeting.

Authors:  Helene Bayer; Katharina Essig; Sven Stanzel; Martin Frank; Jeffrey C Gildersleeve; Martin R Berger; Cristina Voss
Journal:  J Biol Chem       Date:  2012-08-07       Impact factor: 5.157

2.  Lactosyl-sepharose binding proteins from pancreatic cancer cells show differential expression in primary and metastatic organs.

Authors:  Micah N Sagini; Karel D Klika; Agnes Hotz-Wagenblatt; Michael Zepp; Martin R Berger
Journal:  Exp Biol Med (Maywood)       Date:  2020-03-04

3.  Riproximin modulates multiple signaling cascades leading to cytostatic and apoptotic effects in human breast cancer cells.

Authors:  Asim Pervaiz; Michael Zepp; Hassan Adwan; Martin R Berger
Journal:  J Cancer Res Clin Oncol       Date:  2015-07-12       Impact factor: 4.553

4.  Expression profiling of anticancer genes in colorectal cancer patients and their in vitro induction by riproximin, a ribosomal inactivating plant protein.

Authors:  Asim Pervaiz; Talha Saleem; Kinzah Kanwal; Syed Mohsin Raza; Sana Iqbal; Michael Zepp; Rania B Georges; Martin R Berger
Journal:  J Cancer Res Clin Oncol       Date:  2022-10-17       Impact factor: 4.322

5.  Riproximin's activity depends on gene expression and sensitizes PDAC cells to TRAIL.

Authors:  Hassan Adwan; Ahmed Murtaja; Khamael Kadhim Al-Taee; Asim Pervaiz; Thomas Hielscher; Martin R Berger
Journal:  Cancer Biol Ther       Date:  2014-06-11       Impact factor: 4.742

Review 6.  Ribosome-inactivating and related proteins.

Authors:  Joachim Schrot; Alexander Weng; Matthias F Melzig
Journal:  Toxins (Basel)       Date:  2015-05-08       Impact factor: 4.546

7.  Riproximin Exhibits Diversity in Sugar Binding, and Modulates some Metastasis-Related Proteins with Lectin like Properties in Pancreatic Ductal Adenocarcinoma.

Authors:  Micah N Sagini; Karel D Klika; Andrew Orry; Michael Zepp; Joshua Mutiso; Martin R Berger
Journal:  Front Pharmacol       Date:  2020-11-30       Impact factor: 5.810

8.  Integration of medicinal plants into the traditional system of medicine for the treatment of cancer in Sokoto State, Nigeria.

Authors:  Ibrahim Malami; Nasiru Muhammad Jagaba; Ibrahim Babangida Abubakar; Aliyu Muhammad; Alhassan Muhammad Alhassan; Peter Maitama Waziri; Ibrahim Zakiyya Yakubu Yahaya; Halilu Emmanuel Mshelia; Sylvester Nefy Mathias
Journal:  Heliyon       Date:  2020-09-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.